Acobiom:企業の製品パイプライン分析2018

【英語タイトル】Acobiom - Product Pipeline Analysis, 2018 Update

GlobalDataが出版した調査資料(DATA904C2875)・商品コード:DATA904C2875
・発行会社(調査会社):GlobalData
・発行日:2018年8月
・ページ数:38
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD750 ⇒換算¥81,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD1,500 ⇒換算¥163,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD2,250 ⇒換算¥245,250見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Summary
Acobiom is a biotechnology company that specializes in biomarker discovery and development of innovative diagnostics. The company undertakes the discovery of RNA and DNA biomarkers, which finds application in the areas of disease detection and classification, patient stratification, companion diagnosis and disease prognosis. It develops diagnostics centered on personalized medicine and precision medicine applications. Acobiom also provides services such as sequencing, next generation sequencing (NGS), bioinformatics, biostatistics, real time PCR, and others. The company offers technology platforms such as qRT-PCR, gene expression and bioinformatics. The company provides products in the areas of personalized medicines, medical products, leukemia and gemcitest, among others. Acobiom is headquartered in Montpellier, France.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Acobiom
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Acobiom Company Overview 5
Acobiom Company Snapshot 5
Acobiom Pipeline Products and Ongoing Clinical Trials Overview 5
Acobiom – Pipeline Analysis Overview 8
Acobiom – Key Facts 8
Acobiom – Major Products and Services 9
Acobiom Pipeline Products by Development Stage 10
Acobiom Ongoing Clinical Trials by Trial Status 14
Acobiom Pipeline Products Overview 15
Biomarker Test – Hantavirus 15
Biomarker Test – Hantavirus Product Overview 15
Companion Diagnostic Assay – Masitinib 16
Companion Diagnostic Assay – Masitinib Product Overview 16
Companion Diagnostic Assay – Prostate Cancer 17
Companion Diagnostic Assay – Prostate Cancer Product Overview 17
Companion Diagnostic Test – Alzheimer’s Disease 18
Companion Diagnostic Test – Alzheimer’s Disease Product Overview 18
Companion Diagnostic Test – Breast Cancer 19
Companion Diagnostic Test – Breast Cancer Product Overview 19
Companion Diagnostic Test – Lung Cancer 20
Companion Diagnostic Test – Lung Cancer Product Overview 20
Companion Diagnostic Test – Triple Negative Breast Cancer 21
Companion Diagnostic Test – Triple Negative Breast Cancer Product Overview 21
Diagnostic Assay – Chronic Myelomonocytic Leukemia 22
Diagnostic Assay – Chronic Myelomonocytic Leukemia Product Overview 22
Diagnostic Test – Dengue 23
Diagnostic Test – Dengue Product Overview 23
Diagnostic Test – Leishmania 24
Diagnostic Test – Leishmania Product Overview 24
Diagnostic/Prognostic Assay – Alzheimer’s Disease 25
Diagnostic/Prognostic Assay – Alzheimer’s Disease Product Overview 25
Diagnostic/Prognostic Assay – Breast Cancer 26
Diagnostic/Prognostic Assay – Breast Cancer Product Overview 26
Diagnostic/Prognostic Assay – Lung Cancer 27
Diagnostic/Prognostic Assay – Lung Cancer Product Overview 27
Diagnostic/Prognostic Assay – Pancreatic Cancer 28
Diagnostic/Prognostic Assay – Pancreatic Cancer Product Overview 28
GemciTest 29
GemciTest Product Overview 29
GemciTest Clinical Trial 30
Acobiom – Key Competitors 31
Acobiom – Key Employees 32
Acobiom – Locations And Subsidiaries 33
Head Office 33
Recent Developments 34
Acobiom, Recent Developments 34
Nov 03, 2012: Skuldtech And AB Science Announce Identification Of New Predictive Markers For Pancreatic Cancer Survival Associated With Masitinib Treatment 34
Appendix 35
Methodology 35
About GlobalData 38
Contact Us 38
Disclaimer 38

List of Tables
Acobiom Pipeline Products and Ongoing Clinical Trials Overview 5
Acobiom Pipeline Products by Equipment Type 6
Acobiom Pipeline Products by Indication 7
Acobiom Ongoing Clinical Trials by Trial Status 7
Acobiom, Key Facts 8
Acobiom, Major Products and Services 9
Acobiom Number of Pipeline Products by Development Stage 10
Acobiom Pipeline Products Summary by Development Stage 11
Acobiom Ongoing Clinical Trials by Trial Status 14
Acobiom Ongoing Clinical Trials Summary 14
Biomarker Test - Hantavirus - Product Status 15
Biomarker Test - Hantavirus - Product Description 15
Companion Diagnostic Assay - Masitinib - Product Status 16
Companion Diagnostic Assay - Masitinib - Product Description 16
Companion Diagnostic Assay - Prostate Cancer - Product Status 17
Companion Diagnostic Assay - Prostate Cancer - Product Description 17
Companion Diagnostic Test - Alzheimer's Disease - Product Status 18
Companion Diagnostic Test - Alzheimer's Disease - Product Description 18
Companion Diagnostic Test - Breast Cancer - Product Status 19
Companion Diagnostic Test - Breast Cancer - Product Description 19
Companion Diagnostic Test - Lung Cancer - Product Status 20
Companion Diagnostic Test - Lung Cancer - Product Description 20
Companion Diagnostic Test - Triple Negative Breast Cancer - Product Status 21
Companion Diagnostic Test - Triple Negative Breast Cancer - Product Description 21
Diagnostic Assay - Chronic Myelomonocytic Leukemia - Product Status 22
Diagnostic Assay - Chronic Myelomonocytic Leukemia - Product Description 22
Diagnostic Test - Dengue - Product Status 23
Diagnostic Test - Dengue - Product Description 23
Diagnostic Test - Leishmania - Product Status 24
Diagnostic Test - Leishmania - Product Description 24
Diagnostic/Prognostic Assay - Alzheimer's Disease - Product Status 25
Diagnostic/Prognostic Assay - Alzheimer's Disease - Product Description 25
Diagnostic/Prognostic Assay - Breast Cancer - Product Status 26
Diagnostic/Prognostic Assay - Breast Cancer - Product Description 26
Diagnostic/Prognostic Assay - Lung Cancer - Product Status 27
Diagnostic/Prognostic Assay - Lung Cancer - Product Description 27
Diagnostic/Prognostic Assay - Pancreatic Cancer - Product Status 28
Diagnostic/Prognostic Assay - Pancreatic Cancer - Product Description 28
GemciTest - Product Status 29
GemciTest - Product Description 29
GemciTest - Clinical Evaluation of GemciTest in the Treatment of Pancreatic Cancer Patients 30
Acobiom, Key Employees 32
Glossary 37

List of Figures
Acobiom Pipeline Products by Equipment Type 6
Acobiom Pipeline Products by Development Stage 10
Acobiom Ongoing Clinical Trials by Trial Status 14

★調査レポート[Acobiom:企業の製品パイプライン分析2018] (コード:DATA904C2875)販売に関する免責事項を必ずご確認ください。
★調査レポート[Acobiom:企業の製品パイプライン分析2018]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆